. Author manuscript; available in PMC: 2009 May 1.

Published in final edited form as: Neuropsychopharmacology. 2008 Jun 4;34(6):1363–1380. doi: 10.1038/npp.2008.76

Table 1.

Proportional representations (%) of transcripts with enriched glial or neuronal origin within groups of identified genes

Cellular enrichment of gene transcripts

	# Genes	~Neuronal (%)	Both (%)	~Glial (%)
CC		24^*	56^*	20^*
‘Mood and therapeutic’	146	19	53	28
‘Therapeutic only’	238	21	59	20
AMY		23^*	57^*	20^*
‘Mood and therapeutic’	241	23	38	39
‘Therapeutic only’	82	46	37	17
DG		23^*	53^*	24^*
‘Mood and therapeutic’	62	23	48	29
‘Therapeutic only’	19	11	36	53

‘# genes’ indicates the number of genes identified in the respective category.

Italic values with (*) indicate expected proportions of glial- and neuronal-enriched genes (see Materials and methods). Gene categories are described in the text. Bold numbers represent values that are significantly different from expected proportions (χ² tests, P<0.05 adjusted for multiple comparisons). Differences from expected proportions in ‘therapeutic only’ genes were not significant in DG, due to the low number of genes within that category.